- Home
- CLDX vs CMRE Comparison
CLDX vs CMRE Comparison
Compare CLDX & CMRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLDX | CMRE |
|---|---|---|
| Founded | N/A | 1974 |
| Country | United States | Monaco |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.8B |
| IPO Year | 2008 | 2010 |
Fundamental Metrics
Financial Performance| Metric | CLDX | CMRE |
|---|---|---|
| Price | $23.83 | $15.92 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 9 | 1 |
| Target Price | ★ $41.56 | $12.00 |
| AVG Volume (30 Days) | ★ 666.2K | 535.0K |
| Earning Date | 02-26-2026 | 02-06-2026 |
| Dividend Yield | N/A | ★ 2.89% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.51 |
| Revenue | $2,599,000.00 | ★ $2,085,335,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $23.23 | N/A |
| P/E Ratio | ★ N/A | $6.37 |
| Revenue Growth | N/A | ★ 79.87 |
| 52 Week Low | $14.40 | $6.63 |
| 52 Week High | $30.50 | $17.50 |
Technical Indicators
Market Signals| Indicator | CLDX | CMRE |
|---|---|---|
| Relative Strength Index (RSI) | 35.84 | 44.95 |
| Support Level | $22.55 | $15.47 |
| Resistance Level | $25.60 | $17.50 |
| Average True Range (ATR) | 1.05 | 0.51 |
| MACD | -0.30 | -0.10 |
| Stochastic Oscillator | 8.05 | 25.82 |
Price Performance
Historical ComparisonAbout CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About CMRE Costamare Inc. $0.0001 par value
Costamare Inc is an international owner and operator of containerships and dry bulk vessels. The company charter its containerships to the liner companies, providing transportation of containerized cargoes. It charter its dry bulk vessels to a wide variety of customers, providing transportation for dry bulk cargoes. The company's fleet of vessels includes Cosco Guangzhou, Cosco Ningbo, Cosco Yantian, Vantage, Valor, Valiant, Maersk Kobe, and among others. Costamare provides services to ocean carriers that demand a high standard of safety and reliability. It generates a majority of its revenue from the United States of America.